Retail investors rushed to bid for shares in diagnostics firm Thyrocare Technologies Ltd’s initial public offering (IPO) on Wednesday, leading to a 56% subscription on the first of a three-day public issue. The share sale will end on 29 April.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
